Unicredit Bank AG (UC3SB4) News

Chariot Ltd (AIM:CHAR, OTC:OIGLF) chief financial officer Julian Maurice-Williams takes Proactive's Stephen Gunnion through two major announcements from the company's renewable division. The first announcement covers the financing closure of Etana Energy, Chariot’s electricity trading joint venture in South Africa. The financing totals $175 million, with backing from institutions like Norfund and Standard Bank, Africa's biggest bank. Maurice-Williams explained, “Etana is fully funded, and this strengthens its balance sheet, making it bankable and creditworthy.” The second update is a power purchase agreement for a 75-megawatt solar project in South Africa, with electricity to be traded through Etana. This project, set for construction in Q2, was enabled by the guarantee financing secured by Chariot. Maurice-Williams emphasised that these developments mark “two big steps forward for our renewable division towards first revenues.” Chariot expects further renewable projects to reach financial close soon, expanding both its trading and generation revenue streams. The company also continues advancing its oil and gas projects in Morocco and other African markets, with updates expected in the near future. For more updates from Chariot Ltd and other companies, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and turn on notifications for future content. #ChariotLtd #RenewableEnergy #EtanaEnergy #SolarPower #EnergyInvestment #SouthAfricaEnergy #CleanEnergy #FinancialNews #Investing #ProactiveInvestors

Acuity RM Group Plc (AIM:ACRM) CEO David Rajakovich talked with Proactive's Stephen Gunnion about the company's role in the cyber GRC (governance, risk, and compliance) space. Unlike traditional cybersecurity providers, Acuity focuses on real-time risk assessment through its flagship product, STREAM. Rajakovich explained that STREAM functions as a command centre, integrating external data sources to offer a comprehensive view of an organisation's security posture. Rajakovich, who recently took over as CEO, shared his background in scaling businesses, particularly his experience at Skill Dynamics. He highlighted Acuity’s strong presence in government and defence, as well as its growing footprint in financial services and highly regulated industries like pharmaceuticals. The discussion also covered Acuity’s recent acquisition of Rizikon from Crossword Cybersecurity. Rajakovich emphasised that the acquisition was driven by the opportunity to expand Acuity’s customer base, rather than the software itself. Many Rizikon customers are now transitioning to STREAM, benefiting from its broader capabilities. Looking ahead, Rajakovich hinted at upcoming partnerships, particularly within the government and defence sectors. He also outlined Acuity’s two-pronged growth strategy: expanding its mid-market reach through product-led growth and leveraging strategic partnerships to access customers earlier in their cybersecurity journey. With a refined go-to-market strategy and a focus on scalability, Acuity Risk Management is positioning itself for significant growth in the coming years. For more interviews with industry leaders, visit Proactive’s YouTube channel. Don’t forget to like, subscribe, and turn on notifications for future updates. #CyberSecurity #RiskManagement #AcuityRisk #GRC #STREAM #CyberGRC #DataProtection #InfoSec #RiskAssessment #CyberThreats #RegulatoryCompliance #ISO27001 #SOC2 #CyberDefense #BusinessSecurity

Mag Mile Captial CEO Rushi Shah joined Steve Darling from Proactive to discuss the company’s rapid expansion in 2024, highlighted by over $80 million in commercial real estate transactions in just the past two months and an active pipeline of $250 million. Recent closings include a $14.5 million deal in Rochester, New York, and a $13 million transaction in Harker Heights, Texas. Shah emphasized Mag Mile’s transformation into a tech-driven finance company, integrating AI and machine learning to streamline underwriting and deal execution. The firm’s proprietary Cap Logic platform is designed to reduce transaction cycle times by up to 50 times, significantly improving efficiency. Looking ahead, Shah outlined his vision to scale Mag Mile into a $1 billion company through strategic acquisitions and a roll-up strategy, consolidating service providers under the firm’s expanding umbrella. “We are aggressively employing a roll-up strategy,” he noted, reinforcing the company’s commitment to growth. With ample capital, strong demand for real estate financing, and advanced technology integration, Mag Mile Capital is well-positioned to capitalize on industry trends and redefine commercial real estate finance. #proactiveinvestors #magmilecapitalinc #otcqb #mmcp #capital #RealEstateFinance #AIinFinance #CommercialLoans #CRE #Investment #RealEstateInvesting #ProactiveInvestors #CapLogic #Fintech

Race Oncology Ltd chair Peter Smith talked with Proactive about the approval the company has received from the Bellberry Human Research Ethics Committee (HREC). The approval allows the company to move forward with its clinical trial for RC220, a new formulation of bisantrene. Smith explained that the trial aims to establish the safety of RC220 both as a standalone treatment and in combination with doxorubicin, a commonly used chemotherapy drug. "What we’ll be seeking to achieve is establishing the maximum tolerated dose for the combination of the two drugs together," he said. The study will also investigate whether RC220 can reduce doxorubicin’s known toxicity to the cardiovascular system. Smith highlighted that doxorubicin can cause permanent heart damage, potentially reducing patient lifespan by the equivalent of a decade. The company aims to demonstrate that RC220 can enhance anti-cancer effects while mitigating heart-related side effects. The trial will be conducted in multiple phases, beginning in Australia, with expansion planned into Korea and Hong Kong later in the year. Smith noted that the Cancer Care Foundation is playing a role in patient support and accessibility. For more interviews like this, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications for future updates. #RaceOncology #CancerResearch #ClinicalTrial #Biotech #Oncology #RC220 #Doxorubicin #CardioProtection #Pharma #MedicalResearch #CancerTreatment